Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
High PPT1 expression predicts poor clinical outcome and PPT1 inhibitor DC661 enhances sorafenib sensitivity in hepatocellular carcinoma.
Cancer Cell Int. 2022 Mar 11;22(1):115. doi: 10.1186/s12935-022-02508-y.
Cancer Cell Int. 2022.
PMID: 35277179
Free PMC article.
Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
Xu J, Zheng Q, Cheng X, Hu S, Zhang C, Zhou X, Sun P, Wang W, Su Z, Zou T, Song Z, Xia Y, Yi X, Gao Y.
Xu J, et al.
J Nanobiotechnology. 2021 Oct 30;19(1):355. doi: 10.1186/s12951-021-01101-1.
J Nanobiotechnology. 2021.
PMID: 34717654
Free PMC article.
Item in Clipboard
Cite
Cite